Sci-Tech News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Network.

Press releases published on October 2, 2026

Oct. 2, 2026

Traini Partners with TECNO to Bring Native Pet Emotion Translation to Smartphones

Indeterminate GlobeNewswire

Oct. 2, 2026

Chilwa Announces Closing of US$3.5 Million Offering

Indeterminate GlobeNewswire

Oct. 2, 2026

AI-Moderated Telephone Interviews Are Replacing Slow, Costly CATI, and Terapage Reveals How They Actually Work

Indeterminate EIN Presswire

Oct. 2, 2026

YWO launches Partner Boost, a 20% additional-commission campaign for introducing brokers in October 2026

Indeterminate EIN Presswire

Oct. 2, 2026

iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

pMD® Completes Annual SOC 2® Type II and HIPAA Security Audits

Indeterminate GlobeNewswire

Oct. 2, 2026

Pasqal Appoints Roger L. Chuchen as Head of Investor Relations

Indeterminate GlobeNewswire

Oct. 2, 2026

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

Indeterminate GlobeNewswire

Oct. 2, 2026

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Oct. 2, 2026

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

SEALSQ’s Sister Company, WISeSat.Space, Completes Business Combination with Columbus Acquisition Corporation

Indeterminate GlobeNewswire

Oct. 2, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire